Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comment to NCD on Germline Editing and Impact on People with Disabilities
-
Sign-on Letter Supporting the Reducing Hereditary Cancer Act
-
Sign-on Letter Opposing Updated VALID Act & ACM Exemption
-
ACMG Letter Regarding Maryland Medicaid Policy for Carrier Screening
-
Group Sign-on Letter Concerning the Improving Care and Access to Nurses (I CAN) Act
-
Joint Statement on Lawsuit Threatening Preventive Healthcare
-
Sign-on Letter to Congressional Leadership Concerning the VALID Act
-
ACMG Comments on FDA Draft Guidance for Products Incorporating Genome Editing
-
Group Sign-on Letter Concerning the VALID Act of 2022 Discussion Draft
-
ACMG Response to Opposing Inclusion of the VALID Act in the FDASLA Act